PCI Pharma Services Capabilities Update September 2026: Packaging, Labeling, Logistics

Product volumes now range from scarce, individualized therapies to multi-million-dose monthly demand, and the packaging and assembly partner behind them has to handle both ends.

Paul Spurman, Senior Director of Technical Sales at PCI Pharma Services, speaks to the decisions that shape a clinical-to-commercial transition: matching line speed to batch size, keeping assembly and testing under one roof, storing products from ambient down to cryogenic conditions, and designing cartons that serve patients while meeting new European packaging waste rules. He also touches on logistics strategies for late-stage programs and how validation data from small-scale work can carry forward.

Watch now to hear how he frames partner selection for today's portfolio and the one that follows.